HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Diabetes & Endocrinology
Cohort
Atherogenic Index of Plasma Shows Limited Discrimination for Predicted CVD High-Risk Status in Chinese Screening Cohort
Blood fat ratio linked to predicted heart disease risk in Chinese screening study
A cross-sectional cohort analysis of 6,702 community screening participants in China found that higher atherogenic index of plasma (AIP) was…
A simple blood test ratio called AIP helps predict heart disease risk better when combined with other health data in a large Chinese screeni…
Frontiers
Apr 5, 2026
Diabetes & Endocrinology
Cohort
Lipoprotein(a) shows substantial longitudinal variability in children with type 1 diabetes
Does a child's heart risk marker change over time? New study finds surprising variability
A retrospective single-center cohort study of 287 children and adolescents with type 1 diabetes found that 32% exhibited intraindividual Lp(…
A child's heart risk marker can swing wildly over time, with nearly 12% of kids crossing a key danger threshold during just six years of mon…
medRxiv
Apr 4, 2026
Physical Medicine & Rehab
Explainable AI system predicts cardiovascular risk with high accuracy but struggles with patient retention
AI system developed to predict heart disease risk and patient retention in Nigeria
A system development study tested CardioAI, an explainable AI system with cardiovascular risk and patient retention modules.
A new AI tool predicts heart disease risk in Nigeria using lifestyle factors, though its ability to forecast patient program completion rema…
medRxiv
Apr 3, 2026
Cardiology
Cohort
ECG abnormalities associated with increased cardiovascular disease risk in REGARDS cohort analysis
Can a simple heart test spot hidden risk in people considered low risk?
A prospective cohort analysis of 19,173 participants without baseline CVD found ECG abnormalities were associated with incident CVD events.
A routine heart test can spot hidden risks in people considered low risk, as those with major ECG abnormalities faced a 53% higher chance of…
medRxiv
Apr 3, 2026
Cardiology
Preliminary U.S. data links underlying health conditions to higher COVID-19 severity risk
Early U.S. data suggests certain health conditions may increase severe COVID-19 risk
A preliminary U.S. observational report suggests patients with COVID-19 who have underlying conditions like diabetes, cardiovascular disease…
Early U.S. data suggests people with diabetes, heart disease, lung issues, or who smoke face higher risk for severe COVID-19 requiring hospi…
CDC
Apr 2, 2026
Cardiology
Report examines cardiovascular health and predicted heart age in US cancer survivors
Researchers examine cardiovascular health and heart age in US cancer survivors
An observational report describes cardiovascular health and predicted heart age in cancer survivors in the United States.
A new report examines predicted heart age among US cancer survivors to understand their cardiovascular health challenges.
CDC
Apr 2, 2026
Nephrology
Meta-analysis
Metabolic syndrome associated with higher cardio-renal risk in kidney transplant recipients
Metabolic syndrome linked to higher risks for heart problems and kidney graft issues after transplant
A meta-analysis of 8,986 kidney transplant recipients found metabolic syndrome was associated with higher risks of major adverse cardiovascu…
Kidney transplant patients with metabolic syndrome face double the risk of major heart events and higher chances of graft failure or death.
Apr 1, 2026
Nephrology
Phase III
TRACK trial to assess low-dose rivaroxaban for MACE in advanced CKD/dialysis patients
Can a low-dose blood thinner protect people with advanced kidney disease from heart attacks and strokes?
The TRACK trial is a global, quadruple-blind, placebo-controlled phase 3 study evaluating low-dose rivaroxaban (2.5 mg) for reducing major a…
A new global study tested whether a low-dose blood thinner safely protects people with advanced kidney disease from heart attacks and stroke…
CT.gov
Mar 30, 2026